"The Sellersville site can also produce liquids, creams, and ointments, further expanding the PPS portfolio," the statement said.
The site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency(EMA), it added.
"Many of our customers are looking for US-based manufacturing partners to expand and support their pipeline. This acquisition strengthens our ability to partner with them on best-in-class drug products,"PPS CEO Peter DeYoung said.
Piramal Pharma Solutions now offers solid oral drug product development and commercial manufacturing in all its major geographies, addressing a previously unmet customer need and strengthening its ability to work globally with customers to reduce the burden of disease on patients, he added.
The company expects to further grow the site's current strength to support development services as well as any Covid-19 management drug opportunities, the statement said.